Is hypercalcemia an independent prognostic factor in Brazilian patients with multiple myeloma?

被引：0
|
作者：
Hungria, V.
Maiolino, A.
Martinez, G.
Colleoni, G.
Coelho, E.
Rocha, L.
Nunes, R.
Bittencourt, R.
Oliveira, L.
Faria, R. M.
Pasquini, R.
Magalhaes, S.
Souza, C. A.
Pinto Neto, J. V.
Barreto, L.
Andrade, E.
机构：
[1] Santa Casa Sao Paulo, Sao Paulo, Brazil
[2] Univ Fed Rio de Janeiro, Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil
[3] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Hosp Sao Paulo, Sao Paulo, Brazil
[5] HEMOPE, Recife, PE, Brazil
[6] Univ Fed Bahia, Hosp Prof Edgar Santos, Salvador, BA, Brazil
[7] Hosp Brigadeiro, Sao Paulo, Brazil
[8] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[9] Hosp Clin Rebeirao Preto, Ribeirao Preto, Brazil
[10] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil
[11] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil
[12] HEMOCE, Fortaleza, Ceara, Brazil
[13] Univ Estadual Campinas, Hosp Clin, Campinas, SP, Brazil
[14] Ctr Oncol & Hematol, Brasilia, DF, Brazil
[15] Inst Nacl Canc, Rio De Janeiro, Brazil
[16] Fdn Ctr Control Oncol, Manaus, Amazonas, Brazil
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [1] CD200 is an independent prognostic factor in multiple myeloma
    Osman, Amany A.
    Eissa, Doaa G.
    Moussa, Mohamed M.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2014, 39 (03): : 177 - 181
  • [2] Serum calcium is an independent prognostic factor of overall survival in Mexican patients with multiple myeloma
    Maillet, Daniela
    Montiel-Cervantes, Laura
    Padilla-Gonzalez, Ysabel
    Sanchez-Cortes, Evelia
    Xolotl-Castillo, Moises
    Vela-Ojeda, Jorge
    Reyes-Maldonado, Elba
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2012, 64 (01): : 17 - 24
  • [3] Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma
    Xu, Limei
    Liu, Junru
    Chen, Meilan
    Kuang, Lifen
    Huang, Beihui
    Gu, Jingli
    Li, Juan
    ANNALS OF HEMATOLOGY, 2020, 99 (03) : 581 - 589
  • [4] Circulating proteasome level is an independent prognostic factor for survival in patients with multiple myeloma.
    Jakob, C
    Egerer, K
    Feist, E
    Zavrski, I
    Eucker, J
    Heider, U
    Burmester, G
    Possinger, K
    Kloetzel, PM
    Sezer, O
    BLOOD, 2004, 104 (11) : 415A - 415A
  • [5] Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma
    Limei Xu
    Junru Liu
    Meilan Chen
    Lifen Kuang
    Beihui Huang
    Jingli Gu
    Juan Li
    Annals of Hematology, 2020, 99 : 581 - 589
  • [6] Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies
    Zagouri, Flora
    Kastritis, Efstathios
    Zomas, Athanasios
    Terpos, Evangelos
    Katodritou, Eirini
    Symeonidis, Argiris
    Delimpasi, Sosana
    Pouli, Anastasia
    Vassilakopoulos, Theodoros P.
    Michalis, Eurydiki
    Giannouli, Stavroula
    Kartasis, Zafiris
    Christoforidou, Anna
    Kokoviadou, Kiriaki
    Hatzimichael, Eleftheria
    Gika, Dimitra
    Megalakaki, Catherine
    Papaioannou, Maria
    Kyrtsonis, Marie-Christine
    Konstantopoulos, Kostas
    Dimopoulos, Meletios A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (05) : 409 - 414
  • [7] Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM)
    Hatic, Haris
    Inselman, Shealeigh
    Inselman, Jonathan
    Kommalapati, Anuhya
    Tella, Sri Harsha
    Paludo, Jonas
    Durani, Urshila
    Go, Ronald S.
    Goyal, Gaurav
    LEUKEMIA RESEARCH, 2022, 123
  • [8] The lung resistance protein is an independent prognostic factor in multiple myeloma.
    Pirker, R
    Filipits, M
    Königsberg, R
    Ackermann, J
    Kittler, H
    Pohl, G
    Gisslinger, H
    Huber, H
    Ludwig, H
    Drach, J
    BLOOD, 1999, 94 (10) : 540A - 540A
  • [9] Time to first treatment is an independent prognostic factor for multiple myeloma (MM).
    Goyal, Gaurav
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Durani, Urshila
    Paludo, Jonas
    Go, Ronald S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma
    Jakob, Christian
    Egerer, Karl
    Liebisch, Peter
    Turkmen, Seval
    Zavrski, Ivana
    Kuckelkorn, Ulrike
    Heider, Ulrike
    Kaiser, Martin
    Fleissner, Claudia
    Sterz, Jan
    Kleeberg, Lorenz
    Feist, Eugen
    Burmester, Gerd-R.
    Kloetzel, Peter-M.
    Sezer, Orhan
    BLOOD, 2007, 109 (05) : 2100 - 2105
12345